-
Hikma taps Hafrun Fridriksdottir as president of generics
Hafrun succeeds Brian Hoffmann, who will leave Hikma effective May 1. -
Alvotech signs U.S. agreement to expand access for high-concentration interchangeable Humira biosimilar
Teva will continue to commercialize adalimumab-ryvk under the Simlandi brand in the U.S.